Research

HCFC1 is a common component of active human CpG-island promoters and coincides with ZNF143, THAP11, YY1, and GABP transcription factor occupancy

    • 1Center for Integrative Genomics, University of Lausanne, Génopode, 1015 Lausanne, Switzerland;
    • 2Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Génopode, 1015 Lausanne, Switzerland
    • Present addresses: 3Gene Predictis SA, Site EPFL, PSE-B, CP 128, 1015 Lausanne, Switzerland;
    • 4 Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA;
    • 5 Laboratory of Cell Cycle Regulation, Centre for DNA Fingerprinting and Diagnostics (CDFD), Nampally, Hyderabad 500001, India.
    • 6 Corresponding author E-mail [email protected]
Published March 28, 2013. Vol 23 Issue 6, pp. 907-916. https://doi.org/10.1101/gr.150078.112
Download PDF Please log-in to or register for your personal account in order to access PDF Cite Article Permissions Share
cover of Genome Research Vol 36 Issue 4
Current Issue:

Abstract

In human transcriptional regulation, DNA-sequence-specific factors can associate with intermediaries that orchestrate interactions with a diverse set of chromatin-modifying enzymes. One such intermediary is HCFC1 (also known as HCF-1). HCFC1, first identified in herpes simplex virus transcription, has a poorly defined role in cellular transcriptional regulation. We show here that, in HeLa cells, HCFC1 is observed bound to 5400 generally active CpG-island promoters. Examination of the DNA sequences underlying the HCFC1-binding sites revealed three sequence motifs associated with the binding of (1) ZNF143 and THAP11 (also known as Ronin), (2) GABP, and (3) YY1 sequence-specific transcription factors. Subsequent analysis revealed colocalization of HCFC1 with these four transcription factors at ∼90% of the 5400 HCFC1-bound promoters. These studies suggest that a relatively small number of transcription factors play a major role in HeLa-cell transcriptional regulation in association with HCFC1.

Loading
Loading
Back to top